Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,242 | 112,346 | 131,503 | 132,295 | 76,026 |
| Marketable Securities | 1,338 | N/A | N/A | N/A | N/A |
| Receivables | 3,320 | 1,528 | 1,619 | 1,888 | 11,308 |
| TOTAL | $105,780 | $115,056 | $134,630 | $136,181 | $87,729 |
| Non-Current Assets | |||||
| PPE Net | 835 | 884 | 931 | 992 | 975 |
| Investments And Advances | 17,564 | 15,422 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,527 | 1,579 | 1,625 | 1,624 | 1,731 |
| TOTAL | $19,926 | $17,885 | $2,556 | $2,616 | $2,706 |
| Total Assets | $125,706 | $132,941 | $137,186 | $138,797 | $90,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 683 |
| Accounts payable and accrued liabilities | 2,582 | 3,038 | 2,085 | 2,973 | 2,855 |
| Other current liabilities | 7 | 836 | 1,264 | 2,644 | 364 |
| TOTAL | $2,945 | $4,230 | $3,698 | $5,959 | $4,238 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 98 |
| Other Non-Current Liabilities | 1,262 | 1,593 | 1,751 | 2,175 | 1,848 |
| TOTAL | $1,262 | $1,593 | $1,751 | $2,175 | $1,946 |
| Total Liabilities | $4,207 | $5,823 | $5,449 | $8,134 | $6,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,424 | 34,423 | 35,319 | 35,154 | 28,507 |
| Common Shares | 3 | 4 | 4 | 3 | 3 |
| Retained earnings | -268,893 | -267,029 | -264,326 | -262,567 | -268,770 |
| Other shareholders' equity | 464 | 186 | 0 | 0 | 0 |
| TOTAL | $121,499 | $127,118 | $131,737 | $130,663 | $84,251 |
| Total Liabilities And Equity | $125,706 | $132,941 | $137,186 | $138,797 | $90,435 |